In a new study from the University of Strathclyde and spinout company Dxcover, researchers show that early detection of brain cancer has moved one step closer.
They showed that their innovative testing technology, the Dxcover Liquid Biopsy, is effective even in the earlier days of cancer growth, at a smaller volume and lower stage.
According to Cancer Research UK, 12,000 people in Britain are diagnosed with brain tumors every year and survival rates are as low as 12% five years after diagnosis.
Earlier detection, when a tumor is smaller, reduces the harm from surgery and other treatments, so people can live better, for longer.
By detecting extremely small tumors, this research provides evidence that Dxcover’s diagnostic test can have a significant impact in shortening the time from symptom onset to diagnosis for patients, supporting primary care doctors in their decision making.
The study demonstrates the effectiveness of our Dxcover Brain Cancer Liquid Biopsy at detecting even the smallest brain tumors.
This is great news for the care of future brain cancer patients, increasing treatment options and potentially extending life expectancy.
In the study, the team confirmed the Dxcover brain cancer test as being effective in identifying small and low-grade gliomas.
The study involved 177 patients with varying sizes of brain tumors providing blood samples for analysis by Dxcover.
The samples underwent spectroscopic analysis under infra-red light and were processed using machine learning software.
The test and analysis were found to be effective in identifying brain tumors in patients with gliomas as small as 0.2 cm3.
The team says these highly effective early diagnostic tests could revolutionize cancer detection, potentially saving the lives of patients who can be treated more effectively in the early stages of cancer.
The core patents have been granted in Europe, the U.S. and China and they enable researchers to develop tests for all types of cancer.
If you care about brain cancer, please read studies about this anti-malarial drug shows promise for treating deadly brain cancer and findings of new treatment shows promise in fighting deadly brain cancer.
For more information about brain cancer and your health, please see recent studies about a major cause of deadly brain cancer and results showing that a new way to treat brain cancer and Alzheimer’s disease.
The study is published in Cancers. One author of the study is Dr. Matt Baker.
Copyright © 2021 Knowridge Science Report. All rights reserved.
